Abstract
Cardiovascular diseases are one of the major causes of mortality in the western world. As platelet dependent thrombosis is of central importance in their pathophysiology, several successful strategies, targeting a specific platelet function or interaction, have been developed to prevent or treat these disorders. However, as the current antiplatelet strategies are limited in efficacy and safety, and often influence normal haemostatic functions, new compounds are being developed with improved characteristics. This review deals with the development of novel antiplatelet compounds for which evidence is available on their antithrombotic action in vivo. In a first part, these compounds, their targets and their potential applicability are discussed. The second part of this review focuses on BT tests and bleeding models and their usefulness for determination and / or prediction of the safety of novel antiplatelet compounds.
Keywords: antiplatelet therapy, bleeding, thrombosis
Current Medicinal Chemistry
Title: New Approaches for Antithrombotic Antiplatelet Therapies
Volume: 11 Issue: 17
Author(s): H. Ulrichts, K. Vanhoorelbeke, G. Van de Walle, S. Katsutani, S. De Meyer, S. Staelens and H. Deckmyn
Affiliation:
Keywords: antiplatelet therapy, bleeding, thrombosis
Abstract: Cardiovascular diseases are one of the major causes of mortality in the western world. As platelet dependent thrombosis is of central importance in their pathophysiology, several successful strategies, targeting a specific platelet function or interaction, have been developed to prevent or treat these disorders. However, as the current antiplatelet strategies are limited in efficacy and safety, and often influence normal haemostatic functions, new compounds are being developed with improved characteristics. This review deals with the development of novel antiplatelet compounds for which evidence is available on their antithrombotic action in vivo. In a first part, these compounds, their targets and their potential applicability are discussed. The second part of this review focuses on BT tests and bleeding models and their usefulness for determination and / or prediction of the safety of novel antiplatelet compounds.
Export Options
About this article
Cite this article as:
Ulrichts H., Vanhoorelbeke K., Walle Van de G., Katsutani S., Meyer De S., Staelens S. and Deckmyn H., New Approaches for Antithrombotic Antiplatelet Therapies, Current Medicinal Chemistry 2004; 11 (17) . https://dx.doi.org/10.2174/0929867043364630
DOI https://dx.doi.org/10.2174/0929867043364630 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Matrix Metalloproteinases: New Routes to the Use of MT1-MMP As A Therapeutic Target in Angiogenesis-Related Disease
Current Pharmaceutical Design Which way in? The Necessity of Multiple Approaches to Transcatheter Valve Therapy
Current Cardiology Reviews Transseptal Access to the Left Atrium: Tips and Tricks to Keep it Safe Derived from Single Operator Experience and Review of the Literature
Current Cardiology Reviews Potential Effect of Anti-Tumour Necrosis Factor-Alpha Treatment on Reducing the Cardiovascular Risk Related to Rheumatoid Arthritis
Current Vascular Pharmacology Fibrinolysis at the Fluid-Solid Interface of Thrombi
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Molecular Targets in Osteoarthritis: Metalloproteinases and Their Inhibitors
Current Drug Targets Training Standards and Recommendations for Intervention on Chronic Total Occlusions
Current Cardiology Reviews Modified Fibrin Hydrogel Matrices: Both, 3D-Scaffolds and Local and Controlled Release Systems to Stimulate Angiogenesis
Current Pharmaceutical Design Inflammation, Adiponectin, Obesity and Cardiovascular Risk
Current Medicinal Chemistry Effect of Antenatal Steroids on Haemodynamics in the Normally Grown and Growth Restricted Fetus
Current Pediatric Reviews Meet Our Editorial Board Member
Current Vascular Pharmacology Endothelial Dysfunction in Heart Failure: Mechanisms and Therapeutic Approaches
Current Vascular Pharmacology Obesity Modulation - The Role in Carcinogenesis
Anti-Cancer Agents in Medicinal Chemistry Mechanisms of Vascular Calcification and Associated Diseases
Current Pharmaceutical Design Dl-3-n-Butylphthalide (NBP): A Promising Therapeutic Agent for Ischemic Stroke
CNS & Neurological Disorders - Drug Targets Stent Thrombosis - Mythy and Facts
Cardiovascular & Hematological Disorders-Drug Targets Early-phase 18F-AV-45 PET Imaging can Detect Crossed Cerebellar Diaschisis Following Carotid Artery Stenosis and Cerebral Hypoperfusion
Current Neurovascular Research Angiogenesis and Vascularization of Uterine Leiomyoma: Clinical Value of Pseudocapsule Containing Peptides and Neurotransmitters
Current Protein & Peptide Science Vascular Toxicity of Chemotherapeutic Agents
Current Vascular Pharmacology Magnesium Lithospermate B Extracted from Salvia Miltiorrhiza, A Potential Substitute for Cardiac Glycosides
Mini-Reviews in Organic Chemistry